Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.

For these patients with detectable cell proliferation, inhibitor treatment resulted in a highly significant antiproliferative effect compared to untreated controls ( p ≤ 0.0001, Kruskal Wallis test, Dunn ́s post-hoc test), for all inhibitors except lonidamine and AZD3965.

also in 132,142 other papers

A few associations of borderline significance were detected ( p < 0.05, Table S2 ).

also in 2,624 other papers